» Articles » PMID: 26955300

Mechanically Tunable Hollow Silica Ultrathin Nanoshells for Ultrasound Contrast Agents

Overview
Journal Adv Funct Mater
Date 2016 Mar 9
PMID 26955300
Citations 21
Authors
Affiliations
Soon will be listed here.
Abstract

Perfluoropentane (PFP) gas filled biodegradable iron-doped silica nanoshells have been demonstrated as long-lived ultrasound contrast agents. Nanoshells are synthesized by a sol-gel process with tetramethyl orthosilicate (TMOS) and iron ethoxide. Substituting a fraction of the TMOS with R-substituted trialkoxysilanes produces ultrathin nanoshells with varying shell thicknesses and morphologies composed of fused nanoflakes. The ultrathin nanoshells had continuous ultrasound Doppler imaging lifetimes exceeding 3 hours, were twice as bright using contrast specific imaging, and had decreased pressure thresholds compared to control nanoshells synthesized with just TMOS. Transmission electron microscopy (TEM) showed that the R-group substituted trialkoxysilanes could reduce the mechanically critical nanoshell layer to 1.4 nm. These ultrathin nanoshells have the mechanical behavior of weakly linked nanoflakes but the chemical stability of silica. The synthesis can be adapted for general fabrication of three-dimensional nanostructures composed of nanoflakes, which have thicknesses from 1.4-3.8 nm and diameters from 2-23 nm.

Citing Articles

Micro/nanosystems for controllable drug delivery to the brain.

Tian M, Ma Z, Yang G Innovation (Camb). 2024; 5(1):100548.

PMID: 38161522 PMC: 10757293. DOI: 10.1016/j.xinn.2023.100548.


Medical Imaging Technology for Micro/Nanorobots.

Liu X, Jing Y, Xu C, Wang X, Xie X, Zhu Y Nanomaterials (Basel). 2023; 13(21).

PMID: 37947717 PMC: 10648532. DOI: 10.3390/nano13212872.


Ultrasound contrast agents from microbubbles to biogenic gas vesicles.

Zeng W, Yue X, Dai Z Med Rev (2021). 2023; 3(1):31-48.

PMID: 37724107 PMC: 10471104. DOI: 10.1515/mr-2022-0020.


A Novel Platform of MOF for Sonodynamic Therapy Advanced Therapies.

Liao D, Huang J, Jiang C, Zhou L, Zheng M, Nezamzadeh-Ejhieh A Pharmaceutics. 2023; 15(8).

PMID: 37631285 PMC: 10458442. DOI: 10.3390/pharmaceutics15082071.


Emerging photodynamic/sonodynamic therapies for urological cancers: progress and challenges.

Hu X, Zhang Y, Liu Y, Wang N, Zeng X, Zhang L J Nanobiotechnology. 2022; 20(1):437.

PMID: 36195918 PMC: 9531473. DOI: 10.1186/s12951-022-01637-w.


References
1.
Sonne C, Xie F, Lof J, Oberdorfer J, Phillips P, Everbach E . Differences in definity and optison microbubble destruction rates at a similar mechanical index with different real-time perfusion systems. J Am Soc Echocardiogr. 2003; 16(11):1178-85. DOI: 10.1067/j.echo.2003.07.001. View

2.
Nozawa K, Gailhanou H, Raison L, Panizza P, Ushiki H, Sellier E . Smart control of monodisperse Stöber silica particles: effect of reactant addition rate on growth process. Langmuir. 2005; 21(4):1516-23. DOI: 10.1021/la048569r. View

3.
Giri S, Trewyn B, Stellmaker M, Lin V . Stimuli-responsive controlled-release delivery system based on mesoporous silica nanorods capped with magnetic nanoparticles. Angew Chem Int Ed Engl. 2005; 44(32):5038-44. DOI: 10.1002/anie.200501819. View

4.
Cosgrove D . Ultrasound contrast agents: an overview. Eur J Radiol. 2006; 60(3):324-30. DOI: 10.1016/j.ejrad.2006.06.022. View

5.
Slowing I, Trewyn B, Lin V . Mesoporous silica nanoparticles for intracellular delivery of membrane-impermeable proteins. J Am Chem Soc. 2007; 129(28):8845-9. DOI: 10.1021/ja0719780. View